title: [Cisapride treatment for children with gastro-esophageal reflux].
abstract: The prokinetic drug cisapride is widely used for treating gastro-oesophageal reflux in infants and children. As in the Netherlands it is not officially registered for use in these age groups, prescribing doctors have problems obtaining adequate information on proper use and side effects. In the treatment of pediatric gastro-oesophageal reflux with cisapride the major recommendations include not to exceed the maximum dose of 0.2 mg/kg four times daily, to avoid comedication with imidazoles and macrolides and to check the QTc interval in patients with known risk factors for QTc prolongation.
authors.affiliation: Academisch Ziekenhuis Vrije Universiteit, afd. Kindergeneeskunde, Amsterdam.
authors.forename: C M
authors.initials: CM
authors.lastname: Kneepkens
authors.forename: J H
authors.initials: JH
authors.lastname: Hoekstra
authors.forename: Y
authors.initials: Y
authors.lastname: Vandenplas
mesh_terms: D002648:Child; D020117:Cisapride / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017277:Drug Approval; D004347:Drug Interactions; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008133:Long QT Syndrome / Q000139:chemically induced; D009426:Netherlands
chemical_list: D005765:Gastrointestinal Agents; D020117:Cisapride